(Q77579335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Calcium antagonists and cardiovascular risk in diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

H H Parving

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

42R-44R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Calcium channel blockers and cardiovascular risk in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Diabetes and risk of adverse events with calcium antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Morbidity, mortality, and albuminuria in type 2 diabetic patients: a three-year prospective study of a random cohort in general practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Prospective study of microalbuminuria as predictor of mortality in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Albumin excretion and vascular deaths in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Albuminuria and poor glycemic control predict mortality in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Calcium-channel blockers for hypertension--uncertainty continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Aspirin therapy in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Hypertension Optimal Treatment (HOT) trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

Treatment of hypertension in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900758-9

10.1016/S0002-9149(98)00758-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822145%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference